Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.8 USD | +2.51% | +4.56% | -5.05% |
04-26 | IBM Delivers on Two Key Metrics in 'Solid' Q1 Despite Revenue Miss, RBC Says | MT |
04-26 | BNP Paribas Adjusts Price Target on Healthpeak Properties to $21 From $19 | MT |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- With an expected P/E ratio at 48.35 and 31.76 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.05% | 13.23B | A | ||
+4.62% | 55.76B | A- | ||
-11.72% | 17.72B | A- | ||
+1.40% | 7.68B | B | ||
-16.54% | 5.39B | B- | ||
+8.62% | 3.28B | C- | ||
-5.42% | 3.06B | B+ | ||
-8.15% | 2.73B | C | ||
+12.61% | 2.73B | C- | ||
-13.17% | 2.43B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DOC Stock
- Ratings Healthpeak Properties, Inc.